PPAR agonists for primary biliary cholangitis

被引：3
作者：
Gossard, Andrea A. [1 ]
Gores, Gregory J. [1 ]
机构：
[1] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2017年 / 2卷 / 10期
关键词：
URSODEOXYCHOLIC ACID THERAPY; BIOCHEMICAL RESPONSE; CIRRHOSIS; BEZAFIBRATE;
D O I：
10.1016/S2468-1253(17)30256-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：693 / 694
页数：3
相关论文
共 11 条
  • [1] The X chromosome and immune associated genes
    Bianchi, Ilaria
    Lleo, Ana
    Gershwin, M. Eric
    Invernizzi, Pietro
    [J]. JOURNAL OF AUTOIMMUNITY, 2012, 38 (2-3) : J187 - J192
  • [2] The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
    Corpechot, C
    Carrat, F
    Bahr, A
    Chrétien, Y
    Poupon, RE
    Poupon, R
    [J]. GASTROENTEROLOGY, 2005, 128 (02) : 297 - 303
  • [3] A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)
    Corpechot, C.
    Chazouilleres, O.
    Rousseau, A.
    Guyader, D.
    Habersetzer, F.
    Mathurin, P.
    Goria, O.
    Potier, P.
    Minello, A.
    Silvain, C.
    Abergel, A.
    Debette-Gratien, M.
    Larrey, D.
    Roux, O.
    Bronowicki, J. -P.
    Boursier, J.
    De Ledhingen, V.
    Heurgue-Berlot, A.
    Nguyen-Khac, E.
    Zoulim, F.
    Ollivier-Hourmand, I.
    Zarski, J. -P.
    Nkontchou, G.
    Gaouar, F.
    Simon, T.
    Poupon, R.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S89 - S89
  • [4] Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
    Corpechot, Christophe
    Abenavoli, Ludovico
    Rabahi, Nabila
    Chretien, Yves
    Andreani, Tony
    Johanet, Catherine
    Chazouilleres, Olivier
    Poupon, Raoul
    [J]. HEPATOLOGY, 2008, 48 (03) : 871 - 877
  • [5] Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysis
    Grigorian, Alla Y.
    Mardini, Houssam E.
    Corpechot, Christophe
    Poupon, Raoul
    Levy, Cynthia
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2015, 39 (03) : 296 - 306
  • [6] Worldwide Incidence of Autoimmune Liver Disease
    Jepsen, Peter
    Gronbaek, Lisbet
    Vilstrup, Hendrik
    [J]. DIGESTIVE DISEASES, 2015, 33 : 2 - 12
  • [7] Bezafibrate treatment: a new medical approach for PBC patients?
    Kanda, T
    Yokosuka, O
    Imazeki, F
    Saisho, H
    [J]. JOURNAL OF GASTROENTEROLOGY, 2003, 38 (06) : 573 - 578
  • [8] Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid
    Lens, Sabela
    Leoz, Maria
    Nazal, Leyla
    Bruguera, Miguel
    Pares, Albert
    [J]. LIVER INTERNATIONAL, 2014, 34 (02) : 197 - 203
  • [9] Ursodeoxycholic acid for primary biliary cirrhosis
    Lindor, KD
    Poupon, R
    Poupon, R
    Heathcote, EJ
    Therneau, T
    [J]. LANCET, 2000, 355 (9204) : 657 - 658
  • [10] A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
    Nevens, F.
    Andreone, P.
    Mazzella, G.
    Strasser, S. I.
    Bowlus, C.
    Invernizzi, P.
    Drenth, J. P. H.
    Pockros, P. J.
    Regula, J.
    Beuers, U.
    Trauner, M.
    Jones, D. E.
    Floreani, A.
    Hohenester, S.
    Luketic, V.
    Shiffman, M.
    van Erpecum, K. J.
    Vargas, V.
    Vincent, C.
    Hirschfield, G. M.
    Shah, H.
    Hansen, B.
    Lindor, K. D.
    Marschall, H-U
    Kowdley, K. V.
    Hooshmand-Rad, R.
    Marmon, T.
    Sheeron, S.
    Pencek, R.
    MacConell, L.
    Pruzanski, M.
    Shapiro, D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (07) : 631 - 643
12